Ticker Notes

A Glimpse at Otter Tail

2009-11-04T13:09:00.000-08:00

The Fool has a small write up on Otter Tail, one of their Hidden Gems picks. They note that the company is small and obscure, yet is growing well.

Is Paychex Worth $40 a Share

2009-11-02T12:59:00.000-08:00

The Inside Value Team at the Fool have concluded that shares of Paychex are worth $40 a share, a 30% upside to today's price. They also go on to note that shares of Paychex are among their highest eight recommendations right now.

Half Price on 3 Great Stocks

2009-10-28T12:48:00.000-07:00

The Fool writes that the following three stocks are selling at a 50% discount or more:

Costco
Paychex
Medtronic

They note that the favorite of the bunch is Costco as it is poised to take advantage of the recession by drawing more customers through the promise of its customers saving money by buying in bulk.

Hurco: Down But Not Out

2009-10-28T12:45:00.000-07:00

The Fool briefly mentions Hurco, one of their Hidden Gems recommendations in an article today. They note that while the stock has taken a beating lately, a turn-around may be underway. A quote from the article sums everything up:

"If you believe the manufacturing sector will return, Hurco should shine."

The Case for Investing in China

2009-10-19T12:17:00.000-07:00

The Fool makes a strong case for investing in Chinese stocks. They note that George Soros has called investing in China the "investment opportunity of a lifetime."

Stocks mentioned in the article are Jinpan International, a Hidden Gems choice and General Steel, a Global Gains selection.

One To Watch

2009-10-19T12:15:00.000-07:00

The Fool says that Cypress Semiconductor could "explode any day." They speculate that as more technology incorporates uses more touch technology, Cypress will benefit.

DARA Worth A Look

2009-10-13T12:44:00.000-07:00

Zacks lists several reasons why DARA BioSciences is worth a look. They note that the company is coming out of bankruptcy and that they hold several patents for bio technology. They also have two products that are in development, but are expected to show positive progress as the year progresses.

Can Inventiv Double?

2009-10-06T12:57:00.000-07:00

One commentator at the Fool thinks that inVentiv can double. The Fool also owns shares of the company.

Can Manitowoc Multiply

2009-10-05T12:19:00.000-07:00

Notable Calls points out that Deutsche Banks has not only upgraded shares of Manitowoc, but has stated that shares could multiply by 5x over the next three years. That is quite a call and worthy of inspection.

Chinese Medical Technologies: Cheap Growth?

2009-09-18T12:44:00.001-07:00

Chinese Medical Technologies was featured in this article from Zacks that discusses 4 Chinese Growth Stocks. This stock also features a current P/E of 2 and a forward P/E of 7.

Otter Tail

2009-09-15T15:54:00.001-07:00

The Fool has listed Otter Tail as one of its Hidden Gem recommendations.

AmTrust: A Fool Holding

2009-09-14T11:59:00.000-07:00

As disclosed in this article, the Fool owns shares of AmTrust Holdings. The stock sports a P/E of 8, a forward P/E of 5 and a PEG ratio of .48, the stock looks like it is still in value territory.

On Inventive Health

2009-09-10T12:10:00.000-07:00

The Fool certainly favors Inventive Health. They have picked the stock as a Hidden Gems selection, a Stock Advisor selection, and they have purchased shares of the stock with their own money. I don't recall ever reading about a stock that the Fool has supported so strongly.

Bullish on KHD

2009-09-09T12:42:00.000-07:00

The Fool is still bullish on KHD Humboldt Wedag. It owns shares of the stock and has also selected it as a Hidden Gems selection and a Global Gains recommendation.

Two Undervalued Stocks

2009-09-04T15:58:00.001-07:00

According to SA authors, Dawson and Chicago Bridge and Iron are cheap.

An Undervalued Hidden Gem

2009-08-21T15:36:00.000-07:00

The Fool writes that one of their Hidden Gems selections, Innophos Holdings appears to be cheap with its 2.1 P/E ratio and 2.4 P/FCF ratio.

The Case for Stryker

2009-08-17T12:49:00.000-07:00

The Fool makes a good case for owning Stryker in this article. The company is an official Inside Value selection and the Fool owns shares of the company.

$30 Price Target on Human Genome Sciences

2009-08-11T12:10:00.000-07:00

Notables Calls notes that Leerink has set a new price target of $30 on Human Genome Sciences due to the likely hood of positive Phase II trial data for BLISS-76.

On Capital Source

2009-08-05T12:29:00.000-07:00

As disclosed here, the Fool owns shares of Capital Source.

Value in Tucows?

2009-07-31T10:42:00.001-07:00

One author thinks that there is deep value in Tucows.

A Graham Flavored Portfolio

2009-07-31T10:35:00.001-07:00

Seeking Alpha looks at several stocks that Ben Graham would find appealing. The author makes a short case for owning a couple of these stocks, most notably Tidewater and Olin Corp. Value hunters may want to give this list a look and do some additional research.

On Pharmaceutical Product Development

2009-07-28T11:51:00.000-07:00

The Fool has disclosed that Pharmaceutical Product Development is an official MF Stock Pick. The stock has had a bit of a rough time lately as it has suffered an earnings miss and a couple of analyst downgrades. But, as the comments from the article point out, the stock price should recover whenever the economy does.

Graftech International: A MF Holding

2009-07-23T11:33:00.000-07:00

The Fool discloses here that they own shares of Graftech International. Not much else could be found on the company except for a quote by fund manager Mario Gabelli:

"Every time you make a ton of steel, you have to put one of their consumables, carbon graphite, into the furnace," he explained.

"Three years, four years from now, they're going to...have products and technologies that will allow them to get a 15 multiple on peak earnings; you're talking about a stock going from 6 to 45."

Innophos Holdings: A MF Hidden Gem

2009-07-23T11:25:00.000-07:00

The Fool discloses here that Innophos Holdings is an official MF Hidden Gems pick. They also disclose in this article that they own shares of the stock.

Looking at Leucadia National

2009-07-17T12:23:00.000-07:00

The Fool discloses here that Leucadia National is a MF Stock Recommendation. Investopedia has an excellent write-up on the company where they declare that the current stock price is not reflected in the sum of its parts.